Nemani, S.K.
Xiao, X.
Notari, S.
Cali, I.
Lundberg, K.
Cracco, L.
Appleby, B.S.
Surewicz, W.K.
Sim, V.L.
Gambetti, P.
Funding for this research was provided by:
Creutzfeldt-Jakob Disease Foundation
Ottawa Jewish Community Foundation (Alana Bodnoff Perelmutter Fund for Prion Disease Research)
Ottawa Jewish Community Foundation (Alana Bodnoff Perelmutter Fund for Prion Disease Research)
CJD patient family donors
National Institutes of Health (K99/R00 AG068359)
National Institutes of Health (5R01NS128226)
Centers for Disease Control and Prevention (1NU38CK000486)
Article History
Received: 9 May 2025
Accepted: 17 July 2025
First Online: 12 August 2025
Change Date: 27 August 2025
Change Type: Update
Change Details: The original online version of this article was revised: Legends of supplementary figures and tables were missing from this supplementary material and it has been updated.
Declarations
:
: The human brain tissues used in the current study were provided by NPDPSC. All the procedures were performed with institutional review board of University Hospitals Cleveland Medical Center (#5–14 − 09) approval and as per regulations of 1964 Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.